Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.10
+0.07003.45%
Post-market: 2.100.00000.00%16:15 EDT
Volume:622.92K
Turnover:1.32M
Market Cap:151.65M
PE:-1.28
High:2.17
Open:2.02
Low:2.00
Close:2.03
52wk High:3.60
52wk Low:1.50
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.75
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:2.65
PE(LYR):-1.05

Loading ...

Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Sep 17

Acumen Pharmaceuticals Price Target Maintained with a $8.00/Share by BTIG

Dow Jones
·
Sep 17

Acumen Highlights Anti-AβO Pipeline at Investor Day

TIPRANKS
·
Sep 16

Acumen Pharmaceuticals is Maintained at Buy by Citigroup

Dow Jones
·
Sep 16

Citi ups Acumen target, opens ‘upside 90-day catalyst watch’

TIPRANKS
·
Sep 15

Acumen Pharmaceuticals Announces Virtual Investor Day Meeting

Reuters
·
Sep 11

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

ProMIS Neurosciences Q2 Net Loss Widens

Reuters
·
Aug 14

Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)

TIPRANKS
·
Aug 13

Acumen Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Acumen Pharmaceuticals Posts Corporate Presentation on Sabirnetug Antibody Program for Early Alzheimer’s Disease

Reuters
·
Aug 12

Acumen Pharmaceuticals Q2 EPS $(0.45) Misses $(0.34) Estimate

Benzinga Earnings
·
Aug 12

Acumen Pharmaceuticals Q2 Net Loss Widens, Misses Analyst Estimates

Reuters
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Income from Operations USD -32.556 Million Vs. IBES Estimate USD -24.6 Million

Reuters
·
Aug 12

Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights

THOMSON REUTERS
·
Aug 12

Acumen Pharmaceuticals, Inc. Q2 Basic EPS USD -0.45

THOMSON REUTERS
·
Aug 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 11

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Acumen Pharmaceuticals Inc Expected to Post a Loss of 37 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026

GlobeNewswire
·
Aug 06